A novel mechanism of regulation of the anti-metastatic miR-31 by EMSY in breast cancer

Breast Cancer Research

Volumn 16, Issue 1, 2014, Pages

  Mulrane, Laoighse ^a   Gallagher, William M ^a   O'Connor, Darran P ^a  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE DEMETHYLASE; HISTONE DEMETHYLASE KDM5B; MICRORNA 31; TRANSCRIPTION FACTOR ETS 1; UNCLASSIFIED DRUG; MICRORNA; NUCLEAR PROTEIN; REPRESSOR PROTEIN; TUMOR PROTEIN;

ARTICLE; BINDING SITE; BREAST CANCER; DOWN REGULATION; EMSY GENE; GENE AMPLIFICATION; GENE CONTROL; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE LOCUS; GENE TARGETING; HUMAN; ONCOGENE; PROMOTER REGION; REGULATORY MECHANISM; TRANSCRIPTION REGULATION; TRANSCRIPTION TERMINATION; UPREGULATION; ANIMAL; BREAST TUMOR; FEMALE; METABOLISM; PHYSIOLOGY;

ANIMALS; BREAST NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; NEOPLASM PROTEINS; NUCLEAR PROTEINS; REPRESSOR PROTEINS;

EID: 84920831136     PISSN: 14655411     EISSN: 1465542X     Source Type: Journal    
DOI: 10.1186/s13058-014-0467-x     Document Type: Article

References (15)

1. Valastyan S, Reinhardt F, Benaich N, Calogrias D, Szasz AM, Wang ZC, Brock JE, Richardson AL, Weinberg RA: A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis. Cell 2009, 137:1032-1046.
2. Valastyan S, Benaich N, Chang A, Reinhardt F, Weinberg RA: Concomitant suppression of three target genes can explain the impact of a microRNA on metastasis. Genes Dev 2009, 23:2592-2597.
3. Sossey-Alaoui K, Downs-Kelly E, Das M, Izem L, Tubbs R, Plow EF: WAVE3, an actin remodeling protein, is regulated by the metastasis suppressor microRNA, miR-31, during the invasion-metastasis cascade. Int J Cancer 2011, 129:1331-1343.
4. Valastyan S, Chang A, Benaich N, Reinhardt F, Weinberg RA: Concurrent suppression of integrin alpha5, radixin, and RhoA phenocopies the effects of miR-31 on metastasis. Cancer Res 2010, 70:5147-5154.
5. Valastyan S, Chang A, Benaich N, Reinhardt F, Weinberg RA: Activation of miR-31 function in already-established metastases elicits metastatic regression. Genes Dev 2011, 25:646-659.
6. Hughes-Davies L, Huntsman D, Ruas M, Fuks F, Bye J, Chin SF, Milner J, Brown LA, Hsu F, Gilks B, Nielsen T, Schulzer M, Chia S, Ragaz J, Cahn A, Linger L, Ozdag H, Cattaneo E, Jordanova ES, Schuuring E, Yu DS, Venkitaraman A, Ponder B, Doherty A, Aparicio S, Bentley D, Theillet C, Ponting CP, Caldas C, Kouzarides T: EMSY links the BRCA2 pathway to sporadic breast and ovarian cancer. Cell 2003, 115:523-535.
7. Vire E, Curtis C, Davalos V, Git A, Robson S, Villanueva A, Vidal A, Barbieri I, Aparicio S, Esteller M, Caldas C, Kouzarides T: The Breast Cancer Oncogene EMSY Represses Transcription of Antimetastatic microRNA miR-31. Mol Cell 2014, 53:806-818.
8. Curtis C, Shah SP, Chin SF, Turashvili G, Rueda OM, Dunning MJ, Speed D, Lynch AG, Samarajiwa S, Yuan Y, Gräf S, Ha G, Haffari G, Bashashati A, Russell R, McKinney S, METABRIC Group, Langerød A, Green A, Provenzano E, Wishart G, Pinder S, Watson P, Markowetz F, Murphy L, Ellis I, Purushotham A, Børresen-Dale AL, Brenton JD, Tavaré S, Caldas C, Aparicio S: The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups. Nature 2012, 486:346-352.
9. Dvinge H, Git A, Graf S, Salmon-Divon M, Curtis C, Sottoriva A, Zhao Y, Hirst M, Armisen J, Miska EA, Chin SF, Provenzano E, Turashvili G, Green A, Ellis I, Aparicio S, Caldas C: The shaping and functional consequences of the microRNA landscape in breast cancer. Nature 2013, 497:378-382.
10. Melo SA, Esteller M: Dysregulation of microRNAs in cancer: playing with fire. FEBS Lett 2011, 585:2087-2099.
11. Yang Z, Wang L: Regulation of microRNA expression and function by nuclear receptor signaling. Cell Biosci 2011, 1:31.
12. Mulrane L, McGee SF, Gallagher WM, O'Connor DP: miRNA dysregulation in breast cancer. Cancer Res 2013, 73:6554-6562.
13. AugoffK, McCue B, Plow EF, Sossey-Alaoui K: miR-31 and its host gene lncRNA LOC554202 are regulated by promoter hypermethylation in triple-negative breast cancer. Mol Cancer 2012, 11:5.
14. Vrba L, Munoz-Rodriguez JL, Stampfer MR, Futscher BW: miRNA gene promoters are frequent targets of aberrant DNA methylation in human breast cancer. PLoS One 2013, 8:e54398.
15. Bracken CP, Gregory PA, KolesnikoffN, Bert AG, Wang J, Shannon MF, Goodall GJ: A double-negative feedback loop between ZEB1-SIP1 and the microRNA-200 family regulates epithelial-mesenchymal transition. Cancer Res 2008, 68:7846-7854.